[YMAB] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
08-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -48.79%
YoY- -84.49%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 20,251 31,447 12,537 10,797 10,486 9,598 8,965 72.24%
PBT -6,390 1,157 -27,526 -41,131 -28,068 -36,893 -28,858 -63.43%
Tax -1,293 1,558 1,509 1,186 373 1,135 0 -
NP -5,097 -401 -29,035 -42,317 -28,441 -36,893 -28,858 -68.55%
Tax Rate - -134.66% - - - - - -
Total Cost 25,348 31,848 41,572 53,114 38,927 46,491 37,823 -23.43%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -25.17 -1.28 -231.59 -391.93 -271.23 -384.38 -321.90 -81.74%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.12 -0.01 -0.66 -0.97 -0.65 -0.85 -0.66 -67.93%
EPS Diluted -0.12 -0.01 -0.66 -0.97 -0.65 -0.85 -0.66 -67.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.